Quantification of thymosin β4 in human cerebrospinal fluid using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry

Analytical Biochemistry

Volumn 402, Issue 1, 2010, Pages 13-19

  Urso, Elena ^a   Le Pera, Maria ^a   Bossio, Sabrina ^a   Sprovieri, Teresa ^a   Qualtieri, Antonio ^a  

^a INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

Author keywords

Cerebrospinal fluid; Creutzfeldt Jakob disease; MALDI TOF MS

Indexed keywords

BRAIN; DESORPTION; DIAGNOSIS; INDUCTIVELY COUPLED PLASMA; MASS SPECTROMETRY; NEURODEGENERATIVE DISEASES;

CEREBRO SPINAL FLUIDS; CREUTZFELDT-JAKOB DISEASE; HEALTHY INDIVIDUALS; HUMAN CEREBROSPINAL FLUID; INTERNAL STANDARDS; MALDI TOF MS; MATRIX-ASSISTED LASER DESORPTION/IONIZATION-TIME-OF-FLIGHT MASS SPECTROMETRY; PEAK AREA RATIOS;

CEREBROSPINAL FLUID;

THYMOSIN BETA4;

ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC TEST; HUMAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; OXIDATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCREENING TEST; STANDARD;

EID: 77952745388     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2010.03.029     Document Type: Article

References (35)

1. Simpson K.L., Whetton A.D., Dive C. Quantitative mass spectrometry-based techniques for clinical use: biomarker identification and quantification. J. Chromatogr. B 2009, 877:1240-1249.
2. Bantscheff M., Schirle M., Sweetman G., Rick J., Kuster B. Quantitative mass spectrometry in proteomics: a critical review. Anal. Bioanal. Chem. 2007, 389:1017-1031.
3. Gramolini A.O., Peterman S.M., Kislinger T. Mass spectrometry-based proteomics: a useful tool for biomarker discovery?. Clin. Pharmacol. Ther. 2008, 83:758-760.
4. Szajli E., Feher T., Medzihradszky K.F. Investigating the quantitative nature of MALDI-TOF MS. Mol. Cell. Proteomics 2008, 7:2410-2418.
5. Morelle W., Faid V., Chirat F., Michalski J.C. Analysis of N- and O-linked glycans from glycoproteins using MALDI-TOF mass spectrometry. Methods Mol. Biol. 2009, 534:5-21.
6. Bonk T., Humeny A. MALDI-TOF-MS analysis of protein and DNA. Neuroscientist 2001, 7:6-12.
7. Fuchs B., Schiller J. MALDI-TOF MS analysis of lipids from cells, tissues, and body fluids. Subcell. Biochem. 2008, 49:541-565.
8. Fujiwaki T., Tasaka M., Yamaguchi S. Quantitative evaluation of sphingomyelin and glucosylceramide using matrix-assisted laser desorption ionization time-of-flight mass spectrometry with sphingosylphosphorylcholine as an internal standard: practical application to tissues from patients with Niemann-Pick disease types A and C and Gaucher disease. J. Chromatogr. B 2008, 870:170-176.
9. Fujiwaki T., Tasaka M., Takahashi N., Kobayashi H., Murakami Y., Shimada T., Yamaguchi S. Quantitative evaluation of sphingolipids using delayed extraction matrix-assisted laser desorption/ionization time-of-flight mass spectrometry with sphingosylphosphorylcholine as an internal standard: practical application to cardiac valves from a patient with Fabry disease. J. Chromatogr. B 2006, 832:97-102.
10. Ross P.L., Huang Y.N., Marchese J.N., Williamson B., Parker K., Hattan S., Khainovski N., Pillai S., Dey S., Daniels S., Purkayastha S., Juhasz P., Martin S., Bartlet-Jones M., He F., Jacobson A., Pappin D.J. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 2004, 3:1154-1169.
11. Unwin R.D., Pierce A., Watson R.B., Sternberg D.W., Whetton A.D. Quantitative proteomic analysis using isobaric protein tags enables rapid comparison of changes in transcript and protein levels in transformed cells. Mol. Cell. Proteomics 2005, 4:924-935.
12. Shadforth I.P., Dunkley T.P., Lilley K.S., Bessant C. I-Tracker: for quantitative proteomics using iTRAQ. BMC Genomics 2005, 6:145.
13. Ong S.E., Blagoev B., Kratchmarova I., Kristensen D.B., Steen H., Pandey A., Mann M. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 2002, 1:376-386.
14. Gygi S.P., Rist B., Gerber S.A., Turecek F., Gelb M.H., Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 1999, 17:994-999.
15. Gerber S.A., Rush J., Stemman O., Kirschner M.W., Gygi S.P. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc. Natl. Acad. Sci. USA 2003, 100:6940-6945.
16. Westman-Brinkmalm A., Ruetschi U., Portelius E., Andreasson U., Brinkmalm G., Karlsson G., Hansson S., Zetterberg H., Blennow K. Proteomics/peptidomics tools to find CSF biomarkers for neurodegenerative diseases. Front. Biosci. 2009, 14:1793-1806.
17. Luque F.A., Jaffe S.L. Cerebrospinal fluid analysis in multiple sclerosis. Int. Rev. Neurobiol. 2007, 79:341-356.
18. Petzold A. CSF biomarkers for improved prognostic accuracy in acute CNS disease. Neurol. Res. 2007, 29:691-708.
19. Zougman A., Pilch B., Podtelejnikov A., Kiehntopf M., Schnabel C., Kumar C., Mann M. Integrated analysis of the cerebrospinal fluid peptidome and proteome. J. Proteome Res. 2008, 7:386-399.
20. Mohring T., Kellmann M., Jurgens M., Schrader M. Top-down identification of endogenous peptides up to 9kDa in cerebrospinal fluid and brain tissue by nanoelectrospray quadrupole time-of-flight tandem mass spectrometry. J. Mass Spectrom. 2005, 40:214-226.
21. 4 mRNA following focal brain ischemia. NeuroReport 1996, 7:1613-1616.
22. Kim Y., Kim E.H., Hong S., Rhyu I.J., Choe J., Sun W., Kim H. Expression of thymosin beta in the rat brain following transient global ischemia. Brain Res. 2006, 1085:177-182.
23. van Kesteren R.E., Carter C., Dissel H.M., van Minnen J., Gouwenberg Y., Syed N.I., Spencer G.E., Smit A.B. Local synthesis of actin-binding protein β-thymosin regulates neurite outgrowth. J. Neurosci. 2006, 26:152-157.
24. 4 induces adult epicardial progenitor mobilization and neovascularization. Nature 2007, 445:177-182.
25. 4 is differentially expressed in the cerebrospinal fluid of Creutzfeldt-Jakob disease patients: a MALDI-TOF MS protein profiling study. Proteomics Clin. Appl. 2009, 3:574-583.
26. You J.S., Gelfanova V., Knierman M.D., Witzmann F.A., Wang M., Hale J.E. The impact of blood contamination on the proteome of cerebrospinal fluid. Proteomics 2005, 5:290-296.
27. Nicola A.J., Gusev A.I., Proctor A., Jackson E.K., Hercules D.M. Application of the fast-evaporation sample preparation method for improving quantification of angiotensin II by matrix-assisted laser desorption/ionization. Rapid Commun. Mass Spectrom. 1995, 9:1164-1171.
28. Ward D.G., Roberts K., Stonelake P., Goon P., Zampronio C.G., Martin A., Johnson P.J., Iqbal T., Tselepis C. SELDI-TOF-MS determination of hepcidin in clinical samples using stable isotope labelled hepcidin as an internal standard. Proteome Sci. 2008, 6:28.
29. Ranganathan S., Williams E., Ganchev P., Gopalakrishnan V., Lacomis D., Urbinelli L., Newhall K., Cudkowicz M.E., Brown R.H., Bowser R. Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis. J. Neurochem. 2005, 95:1461-1471.
30. M'Koma A.E., Blum D.L., Norris J.L., Koyama T., Billheimer D., Motley S., Ghiassi M., Ferdowsi N., Bhowmick I., Chang S.S., Fowke J.H., Caprioli R.M., Bhowmick N.A. Detection of pre-neoplastic and neoplastic prostate disease by MALDI profiling of urine. Biochem. Biophys. Res. Commun. 2007, 353:829-834.
31. Cazares L.H., Diaz J.I., Drake R.R., Semmes O.J. MALDI/SELDI protein profiling of serum for the identification of cancer biomarkers. Methods Mol. Biol. 2008, 428:125-140.
32. 10. J. Sep. Sci. 2009, 32:57-63.
33. Leitner A., Lindner W. Chemistry meets proteomics: the use of chemical tagging reactions for MS-based proteomics. Proteomics 2006, 6:5418-5434.
34. Sleno L., Volmer D.A. Assessing the properties of internal standards for quantitative matrix-assisted laser desorption/ionization mass spectrometry of small molecules. Rapid Commun. Mass Spectrom. 2006, 20:1517-1524.
35. 4 in human saliva and tears. Ann. NY Acad. Sci. 2007, 1112:458-465.